All4NutraNo products in the cart.
All4NutraStartseite » Polysorbates » Page 17
Solid oral controlled release formulations feature numerous clinical advantages for drug candidates with adequate solubility and dissolution rate. However, most...
Abstract Computational approaches are increasingly explored in development of drug products, including the development of lipid-based formulations (LBFs), to assess...
Abstract Objectives: Skin infections are mild to severe infections often treated with antimicrobial agents. There is an increase in resistance...
Abstract Orally administered medication solubility is a key concern for the pharmaceutical business; about 35-40% of newly introduced pharmaceuticals have...
Abstract Tuberculosis (TB) is an airborne bacterial infection caused by Mycobacterium tuberculosis (M. tb), resulting in approximately 1.3 million deaths in 2022...
Abstract Purpose This investigation aims to develop and characterise dissolving microarray patches (MAPs) loaded with ivermectin (IVM) for rosacea therapy....
Poster presented by Gattefosse and RCPE at the 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical (PBP) Technology, 18 -...
The bioavailability of rivaroxaban at the higher doses (15 and 20 mg) is considerably reduced when the drug is administered on...
Treatment therapies used to manage osteoporosis are associated with severe side effects. So worldwide herbs are widely studied to develop...
The microencapsulation of α-tocopherol based on the complex coacervation of low-molecular-weight chitosan (LMWC) and sodium lauryl ether sulphate (SLES) without...
Copyright: PharmaExcipients AG